comparemela.com

Latest Breaking News On - பிங் ஒரு புத்திசாலி சுகாதாரம் - Page 1 : comparemela.com

China s healthcare market is expected to grow from RMB6 trillion in 2019 to RMB16 trillion in 2030

China s healthcare market is expected to grow from RMB6 trillion in 2019 to RMB16 trillion in 2030 Ping An Leading Digital Revolution in Healthcare Pandemic accelerating shift to online/offline service delivery News provided by Share this article Share this article HONG KONG and SHANGHAI, April 30, 2021 /PRNewswire/ Ping An Insurance (Group) Company of China, Ltd. (hereafter Ping An or the Group , HKEX: 2318; SSE: 601318) is investing in a holistic strategy in digital healthcare to address the challenges of China s rapidly aging population, rising public healthcare costs and a shortage of medical professionals. Digital healthcare spending last year was about 7% of total healthcare spending in China, but the COVID-19 pandemic has driven wider acceptance of online healthcare services among the government, regulators, health care professionals, consumers and companies, Ping An Group Co-CEO Jessica Tan said on McKinsey s Future of Asia podcast.

Ping An AskBob Doctor s Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI

Press release content from PR Newswire. The AP news staff was not involved in its creation. Ping An AskBob Doctor’s Research on Risk Prediction Approach to Tailor Cancer Treatments Published in International Journal JNCI March 9, 2021 GMT HONG KONG and SHANGHAI, March 9, 2021 /PRNewswire/ Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An” or the “Group”, HKEX: 2318; SSE: 601318) is pleased to announce that promising research on the artificial intelligence (AI) technology of Ping An AskBob Doctor has been published in The University of Oxford’s Journal of the National Cancer Institute (JNCI), an important international journal of oncology. The research shows the AI system can effectively categorize nasopharyngeal cancer (NPC) patients by risk level to recommend more refined treatment solutions.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.